Protagonist Therapeutics, Inc. Share Price
Stocks
PTGX
US74366E1029
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 145.87 USD | -0.21% |
|
+6.75% | +67.01% |
| Market Cap | 9.38B 8.11B 7.58B 6.95B 13.08B 893B 13.28B 88.91B 34.9B 448B 35.23B 34.46B 1,479B | P/E 2026 * |
31.2x | P/E 2027 * | -208x |
|---|---|---|---|---|---|
| Enterprise Value | 8.81B 7.62B 7.11B 6.53B 12.28B 838B 12.47B 83.47B 32.76B 420B 33.07B 32.35B 1,389B | EV / Sales 2026 * |
16.3x | EV / Sales 2027 * | 46.3x |
| Free-Float |
97.3% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protagonist Therapeutics, Inc.
| 1 day | -0.21% | ||
| 1 week | +6.75% | ||
| Current month | +6.75% | ||
| 1 month | +3.56% | ||
| 3 months | +47.57% | ||
| 6 months | +72.65% | ||
| Current year | +67.01% |
| 1 week | 131.68 |  | 148 |
| 1 month | 125.32 | | 148 |
| Current year | 77 | | 148 |
| 1 year | 50.58 | | 148 |
| 3 years | 13.72 | | 148 |
| 5 years | 6.91 | | 148 |
| 10 years | 4.47 | | 148 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 30/11/2008 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 17/04/2022 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 30/11/2008 |
Harold Selick
CHM | Chairman | 71 | 18/03/2014 |
William Waddill
BRD | Director/Board Member | 69 | 30/06/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/06/26 | Fiscal year | Director | 27,000 | 0.0420% | ||
| 17/02/26 | Fiscal year | Director | 54,000 | 0.0864% | ||
| 06/02/26 | Fiscal year | Director | 60,000 | 0.0960% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.21% | +6.75% | +186.24% | +670.58% | 9.38B | |
| +0.99% | +1.78% | +4.07% | +16.73% | 49.47B | |
| +3.71% | +9.40% | +486.98% | +592.14% | 43.61B | |
| +5.60% | +10.21% | +16.76% | +85.72% | 39.6B | |
| +2.70% | +1.57% | +33.39% | +8.85% | 39.29B | |
| +2.21% | +6.75% | +21.31% | +53.37% | 32.43B | |
| +2.23% | +4.71% | - | - | 16.84B | |
| +0.97% | +2.35% | +37.75% | +126.84% | 16.49B | |
| -0.11% | +2.41% | +6.24% | +18.87% | 14.01B | |
| +0.75% | +15.04% | +78.59% | +30.30% | 12.77B | |
| Average | +1.88% | +6.36% | +96.82% | +178.16% | 27.39B | |
| Weighted average by Cap. | +2.45% | +6.12% | +107.25% | +160.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 542M 469M 438M 401M 755M 51.56B 767M 5.13B 2.02B 25.84B 2.03B 1.99B 85.44B | 191M 165M 154M 141M 266M 18.14B 270M 1.81B 709M 9.09B 716M 700M 30.05B |
| Net income | 322M 278M 260M 238M 449M 30.63B 456M 3.05B 1.2B 15.35B 1.21B 1.18B 50.75B | -50.04M -43.28M -40.42M -37.08M -69.74M -4.76B -70.85M -474M -186M -2.39B -188M -184M -7.89B |
| Net Debt | -574M -496M -464M -425M -800M -54.62B -813M -5.44B -2.13B -27.38B -2.16B -2.11B -90.51B | -565M -488M -456M -418M -787M -53.75B -800M -5.35B -2.1B -26.94B -2.12B -2.07B -89.06B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | US$145.87 | -0.21% | 321,084 |
| 06/08/26 | US$146.18 | +6.45% | 837,630 |
| 05/08/26 | US$137.32 | +1.11% | 430,528 |
| 04/08/26 | US$135.81 | +2.67% | 634,672 |
| 03/08/26 | US$132.28 | -3.19% | 451,166 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTGX Stock
Select your edition
All financial news and data tailored to specific country editions
